Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Dec 07, 2020 12:52pm
150 Views
Post# 32050083

QSC cash $ 3.31 per share (within one year)

QSC cash $ 3.31 per share (within one year) Worth Repeating my message for the benefit of new investors


I have made a calculation of the projected level of cash that QSC will have in one (1) year.

I base my calculation on my own expecations of the installation of 25 cubes per month, which seems to be more realistic and feasible. 

Therefore here are my calculations:

Total cubes in one year (25/mth):               300

Average testing per cube:                             73

Average sales price per test:                        99

Days in one year                                         365

Projected Sales:                         $ 791,356,500

Net Profit margins                                      55%

Net Profit:                                       395,678,250

Shares o/s                                     149,000,000

Cash per share:                                 $ 2.65  USD

Cash per share                                    3.31  CDN


Note:   I am not including Columbia sales - which will be material
            I am not including the realtors of which there are 500,000 agents
            I am not including the Glenn medicial patients which includes all sports, ie:  NBA
            I am not including 2,000 cubes, instead reducing them to 300
            I am not including full testing patients of 150 people per day but of 73 per day


Therefore what people buy at 23 cents now, will have $ 2.65 in cash per share USD, which is $ 3.31 Canadian per share. 

The numbers speak for themselves. 

MPO
<< Previous
Bullboard Posts
Next >>